NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY ...

Skincare product maker Galderma, and pharmaceutical company Sandoz both returned to their home market this week, bringing ...

Shareholders of Galderma Group AG raised about 1.34 billion Swiss francs ($1.5 billion) from the sale of a roughly 6.3% stake ...

Shareholders of Galderma, the Swiss maker of skincare products including botox, launched a block trade on Monday night to ...

In a report released yesterday, Benjamin Jackson CFA from Jefferies maintained a Buy rating on Galderma Group AG (GALD – Research Report), with ...

ZURICH (Reuters) - Swiss skincare firm Galderma on Thursday posted sales of $4.41 billion for 2024, up 9.3% from the same ...

As part of the Placement, EQT received gross proceeds of c. CHF 354 million. The Placement was completed on 13 March 2025. BNP Paribas, BofA Securities, Goldman Sachs, Morgan Stanley and UBS acted as ...

Berenberg Bank analyst Bethan Davies maintained a Buy rating on Galderma Group AG (GALD – Research Report) yesterday and set a price target of ...

The sale marks another sell-down following Galderma’s IPO last year, with the combined stake of the selling firms now below ...

Galderma Group AG (XSWX:GALD) reports a milestone year with record net sales and profitability, while navigating competitive pressures and market dynamics.

Full Year 2024 Results Key Financial Results Revenue: US$4.44b (up 7.9% from FY 2023).